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Research	on	the	mechanisms	of	diabetes-related	depression	is	limited	by	the	lack	of	sufficiently	
adequate	 animal	models.	Among	 80	 rats,	we	 formed	 four	 groups:	 (i)	 normal	 (N,	 control),	 (ii)	
with	streptozotocin	(STZ)-induced	diabetes mellitus	(group	Dm),	(iii)	with	a	depression	model	
induced by various mild but long-lasting repetitive stressogenic stimulations applied each day 
during	4	weeks	(group	D),	and	(iv)	diabetic	rats	subjected	to	the	combined	action	of	stressogenic	
influences	(group	DmD).	The	latter	group	(35	animals)	was	divided	into	two	subgroups,	DmD1	
subjected	to	the	above	chronic	stressogenic	stimulations,	and	DmD2	in	which	diabetic	rats	were	
during	the	above	period	(4	weeks)	kept	in	isolation.	Rats	of	groups	Dm,	D,	and	DmD	manifested	
clear	behavioral	symptoms	of	depression.	These	symptoms	were	relatively	mild	in	group	Dm	and	
much	more	intense	in	group	DmD.	The	body	mass	of	rats	noticeably	decreased	in	the	Dm	and	D	
groups	and	dramatically	dropped	in	 the	DmD	group.	In	 this	group,	diabetes-related	changes	 in	
the	levels	of	blood	glucose,	insulin,	and	hemoglobin	A1C	were	the	greatest.	The	same	relates	to	
the	behavioral	indices	demonstrated	by	rats	in	the	open	field	test.	The	contents	of	norepinephrine,	
5-hydroxytryptamine,	and	dopamine	in	the	thalamus	of	rats	of	groups	Dm,	D,	and	DmD	were	lower	
than	in	the	norm,	and	these	shifts	where	most	dramatic	in	the	DmD	group.	The	levels	of	ACTH	and	
cortisol	increased	in	the	experimental	groups;	again,	shifts	were	the	greatest	in	the	DmD	group.	
RT	PCR	and	Western	blotting	 showed	 that	 the	 level	 of	NPY	protein	 in	 the	hypothalamus	was	
lower	in	groups	Dm,	D,	and	DmD	than	that	in	the	norm.	Thus,	chronic	unpredictable	stressogenic	
stimulation	 or	 behavioral	 isolation	 of	 diabetic	 rats	 significantly	 aggravates	 manifestations	 of	
depression	 and	 stably	provides	 the	 formation	of	 an	 adequate	 animal	model	of	 diabetes-related	
depression.	Keeping	animals	in	isolation	(subgroup	DmD2)	is	more	suitable	for	empirical	studies	
because	of	a	lower	mortality.
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INTRODUCTION
Diabetes mellitus is a widespread endocrinal systemic 
metabolic	 disease.	 Unhealthy	 psychological	 state,	
character	 defects,	 and	 emotional	 disorders	 are	
usual	 diabetes-related	 pathopsychological	 features.	
Diabetes-induced	 depression	 is	 a	 chronic	 disease;	
it not only disturbs curative effects of therapy and 
worsens the prognosis but also significantly decreases 
the	quality	of	life	of	patients	suffering	from	diabetes.	
The	 suicide	 rate	 in	 diabetes-related	 depression	 is	
higher	 than	 in	 other	 populations	 [1-3].	 Problems	
induced by diabetes mellitus are attracting more and 
more	attention.	Therefore,	the	psychological	treatment	
plays an important role in combined-modality therapy 
of	diabetes.	
So	 far,	 research	 on	 diabetes-related	 depression	
remains	 insufficient,	 and	 there	 is	 a	 deficiency	 in	
adequate	 animal	models	 of	 this	 type	 of	 depression.	
The	aim	of	our	study	was	to	build	an	animal	model	of	
diabetes-related depression that could be sufficiently 
analogous with respect to clinical symptoms of such 
depression	in	humans	and	suitable	for	research.	
METHODS 
Experimental groups. In	 our	 experiments,	 80	
Sprague-Dawely	 (SD)	 male	 rats	 with	 body	 mass	 
180-190	g	were	used.	Rats	were	housed	under	standard	
conditions	 of	 ligh/darkness	 12/12	 h	 (with	 light	 onset	
at	 8:00	 a.m.),	 temperature	 21-23°C,	 and	 humidity	 
40-50%;	food	and	water	were	available	ad libitum.	The	
rats were randomly assigned to one of four distinct 
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groups:	15	 rats	 for	 the	normal	 (N)	group,	15	animals	
for the diabetes mellitus	 (Dm)	group,	which	received	
STZ,	 15	 rats	 for	 the	 depression	 (D)	 group,	 and	 
35	 rats	 for	 the	 diabetes-related	 depression	 (DmD)	
group.	 The	 latter	 group	 was	 separated	 into	 two	
subgroups.	 In	 the	DmD1	subgroup,	15	rats	were	kept	
alone;	while	20	rats	of	the	in	DmD2	subgroup	received	
chronic	unpredictable	stress	stimulation.	
Diabetes mellitus model. The	Dm	and	DmD	groups	
were both subjected to i.p.	 injections	of	0.5	ml	CFA,	
and	STZ	solution	(30	mg/kg)	was	 i.p. injected on the 
next	 day.	The	 injection	was	given	once	 a	week,	 and	
the	cycle	lasted	three	weeks.	The	body	mass	and	blood	
glucose	were	measured	after	the	course	of	injections.	
The	diabetes mellitus model was considered to be built 
successfully when the concentration of blood glucose 
exceeded	16	mM.
Depression model.  The	 D-group	 rats	 were	
subjected in a randomized order to seven distinct 
chronic	 unpredictable	 stresses	 within	 a	 week.	 One	
stress	was	given	each	day,	and	 the	same	stress	could	
not	be	administrated	consecutively.	The	whole	course	
lasted	 for	 4	 weeks.	 The	 methods	 of	 stimulations	
included	 lighting	all	night,	 tilting	 the	cage	 for	17	h,	
water	deprivation	 for	16	h	 followed	by	empty	bottle	
stimulation	 for	 1	 h,	 soft	 constraining	 of	 the	 animal	
for	 3	 h,	 fasting	 for	 24	 h,	 breeding	 in	 the	 group	 for	
17	h,	and	dabbling	 the	cage	for	17	h.	The	depression	
model was considered to be built successfully when 
animals	displayed	a	decrease	in	body	mass,	deficiency	
of	 action,	 novelty-seeking	 and	 aggressive	 behavior,	
and significant decrease in the intensity of grooming 
and	food	consumption.	
Diabetes+depression model. In	 the	DmD	 group,	
rats	 with	 STZ-induced	 diabetes	 were	 subjected	 to	
two types of the above-mentioned stressogenic 
influences	 (subgroups	 DmD1	 and	 DmD2).	 The	
diabetes+depression	model	was	considered	to	be	built	
successively when the rats simultaneously displayed 
changes	 analogous	 to	 those	 in	 the	 above	Dm	 and	D	
groups.	
When	the	models	had	been	built,	the	mental	status,	
state	of	the	motor	activity,	fur	status,	body	mass,	and	
mortality	of	 rats	were	monitored.	The	blood	glucose	
level	was	routinely	measured	by	a	glucometer,	and	the	
glycosylated	hemoglobin	(HbA1C)	level	was	measured	
by	a	respective	analyzer;	 the	procedures	were	mainly	
in	 accordance	 with	 the	 user’s	 guide	 but	 with	 some	
modifications.	Blood	samples	were	taken	from	the	tail	
vein.	
Behavior Testing. A standard open field test was 
used;	it	was	carried	out	in	a	sound-free	and	temperature-	
and	 light-controlled	 room	 at	 7:30	 a.m.	 until	 12:00.	
The	 open	 field	 chamber	 (76×76×42	 cm)	 was	 made	
of	an	opaque	material	with	 the	 floor	divided	 into	25	
equal	 squares.	 The	 observation	 time	 interval	 was	 
5	 min	 long.	 Scores	 of	 horizontal	 movements	
(locomotor	 activity),	 numbers	 of	 rearing	 (vertical	
activity),	 time	spent	 in	 the	central	 square,	number	of	
cleaning	 motions	 (grooming),	 and	 number	 of	 fecal	
boluses	within	 the	above	 interval	were	counted.	The	
apparatus	was	cleaned	between	the	trails.
ELISA test. Blood	samples	were	taken	at	the	onset	
of	sacrifice	and	centrifuged	for	10	min	at	3000	min–1.	
Plasma	was	 then	collected	and	 frozen	at	–80°С	until	
RIA	and	ELISA	measurements.	Insulin	(Ins)	and	ACTH	
levels	were	measured	with	LINCO	(USA)	and	Beijing	
North	 Institute	 of	 Biological	 Technology	 (China)	
kits,	 respectively,	 according	 to	 the	 manufacturer’s	
specifications.	 The	 blood	 samples	 for	 ELISA	 were	
allowed	 to	 stand	 for	 2	 h	 at	 room	 temperature	 and	
centrifuged	at	1000	g	for	20	min.	The	supernatant	was	
taken	for	the	ELISA	test.	The	cortisol	(Cort)	level	was	
quantified	by	an	ELISA	kit	(R	and	D	Systems,	USA).	
HPLC test. Rats	 were	 sacrificed	 24	 h	 after	 the	
experiments.	 The	 thalamus	 was	 placed	 rapidly	 on	
ice,	 weighed,	 and	 stored	 at	 –80°C.	 Reversed-phase	
HPLC with electrochemical detection was used to 
measure	 the	 concentrations	 of	 norepinephrine	 (NE),	
5-hydroxytryptamine	(5-HT),	and	dopamine	(DA).
Real-time PCR. The	 NPY	 mRNA	 level	 was	
measured in the hypothalamus tissue by real-time 
quantitative	PCR.	Samples	of	total-tissue	RNA	(2.5	µg)	 
in	each	group	were	extracted	by	the	Triazole	method.	
The	random	primers	and	M-MLV	were	used	for	reverse	
transcription.	The	NPY	specific	primers	for	real-time	
PCR	were	designed	by	Primer	5.0.	β-Actin	mRNA	was	
used	as	an	 internal	 standard.	The	 real-time	PCR	was	
performed	on	a	real-time	fluorescent	quantitation	PCR	
instrument	(Mastercycler	ep	realplex,	Germany).	The	
NPY	primers	 used	 in	 our	 study	were	 the	 following:	
Forward:	 5’-GTGTGTTTGGGCATTCTGG-3’	 and	
Reverse: 	 5’-GGCATTTTCTGTGCTTTCTCT-3’.	
The 	 p r ime r 	 f o r 	 β - a c t i n 	 we r e 	 Fo rwa rd :	
AACCCTAAGGCCAACAGTGAAAAG	and	Reverse:	
TCATGAGGTAGTCTGTGAGGT.	
Western blotting. Tissue	 samples	 from	 the	
hypothalamus were taken and homogenized in a lysis 
buffer	(5-10	µl/mg	tissue)	containing	a	mixture	of	protease	
inhibitors	(Roche,	Switzerland).	After	incubation	on	ice,	
the	samples	were	centrifuged,	and	the	supernatants	were	
used	for	Western	blotting.	A	BCA	method	was	used	for	
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measuring the concentration and content of protein in 
the	samples.	Equal	amounts	of	 total	protein	 (40-60	µg)	
or	nuclear	protein	(10-20	µg)	were	loaded	and	separated	
in	SDS-PAGE	gel.	The	resolved	proteins	were	transferred	
onto	 polyvinylidene	 difluoride	 (PVDF)	 membranes	
(Amersham	 Bioscience,	 UK).	 The	 PVDF	 membranes	
were	 blocked	 in	 10%	 nonfat	milk	 for	 30	min	 at	 room	
temperature and incubated with rabbit antimouse NPY 
primary	antibody	 (1:	500,	Santa	Cruz,	USA)	overnight	
at	4°C.	Then	 the	membranes	were	 incubated	with	HRP	
goat	antirabbit	secondary	antibody	(1:	2000,	Santa	Cruz,	
USA)	for	1	h	at	the	same	temperature.	The	signals	were	
visualized	 using	 enhanced	 chemiluminescence	 (ECL,	
Pierce,	USA).	The	blots	were	scanned	and	analyzed	with	
a	gel-imaging	analysis	 system	 (Bio-Rad,	USA).	As	 the	
internal	control,	β-actin	was	used.
Statistical analyses. The	 numerical	 data	 in	 this	
study	 were	 analyzed	 with	 SPSS17.0	 software.	 The	
enumeration	 data	 were	 analyzed	 using	 the	 χ2	 test.	
In	 the	 case	of	 normal	 distribution	of	 the	values,	 the	
Student ̕ s t-test was used for estimation of intergroup 
differences;	 in	 other	 cases,	 the	 rank	 sum	 test	 was	
applied.	 For	 all	 experiments,	 the	 differences	 were	
considered significant at P	<	0.05.	
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F i g. 1.	Mean	values	of	the	body	mass	(A)	and	levels	of	blood	glucose,	BG	(B),	insulin,	Ins	(C),	and	hemoglobin	A1C,	HbA1C	(D)	in	the	
examined	groups.	N	is	normal	(control);	Dm,	animals	with	experimental	diabetes mellitus;	D,	rats	with	stress-induced	depression,	and 
DmD1	and	DmD2	are	animals	of	two	subgroups	of	the	diabetes+depression	group.	*P<0,05	and	**	P<0,01,	as	compared	with	group	N,	
+P<0,05	and	++	P<0,01,	as	compared	with	group	Dm,	and	×P<0,05	and	××	P<0,01,	as	compared	with	group	D.
Р и с. 1.	Середні	значення	маси	тіла	(A)	та	рівнів	глюкози	(B),	інсуліну	(C)	та	гемоглобіну	A1C	(D)	у	крові	щурів	досліджених	груп.	
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RESULTS
State of the animals in the diabetes-related 
depression model. We	compared	the	status	of	mental	
abilities,	 motor	 behavior,	 appearance,	 appetite,	
and	 mortality	 between	 all	 model	 groups.	 Rats	 of	
all	 groups	 were	 observed	 for	 12	 weeks	 following	
the	 model	 building.	 When	 the	 models	 were	 formed	
successfully,	 rats	 of	 the	 Dm,	 D,	 and	 DmD	 groups	
displayed	 an	 unhealthy	mental	 status,	 torpid	 actions,	
and	 slow	 reactions	 to	 adequate	 sensory	 stimuli.	
Both	 the	 glossiness	 of	 fur	 and	 body	mass	 decreased	
significantly.	Food	consumption	was	reduced	in	the	D	
group.	Rats	of	the	Dm	and	DmD	groups	demonstrated	
polydipsia,	 polyphagia,	 and	 polyuria.	 Thus,	 there	
were	 some	 common	 symptoms	 in	 the	 three	 groups,	
but the levels of their manifestation were dissimilar 
(see	below).	The	mortality	in	the	groups	was	different.	
After	 the	 above-mentioned	 period	 of	 observation,	 10	
of	 20	 rats	 were	 alive	 in	 the	 DmD2	 subgroup;	 in	 the	
DmD1	and	Dm	groups	this	index	was	12/15	and	13/15,	
respectively;	there	were	no	cases	of	death	in	the	D	and	
N	groups.	
The body mass and levels of blood glucose (BG), 
Ins, and HbA1C in the experimental groups.	The	
mean	body	mass	 and	 levels	 of	BG,	 Ins,	 and	HbA1C	
in the three model groups differed from the respective 
indices	 in	 the	N	 group.	 Compared	 to	 the	 latter,	 the	
body mass and Ins level in the model groups decreased 
significantly (P <	0.01).At	the	same	time,	the	BG	level	
(except	group	D)	and	HbA1C	increased	 in	 the	model	
groups (P <	0.05	or	P <	0.01).	We	found	that	the	means	
of	 the	body	mass,	BG,	Ins,	and	HbA1C	in	 the	DmD1	
and	DmD2	subgroups	were	different	from	those	in	the	
Dm	and	D	groups.	The	 levels	 of	BG	 and	HbA1C	 in	
subgroups	DmD1	and	DmD2	were	higher	 than	 those	
in	 the	Dm	and	D	group,	while	 there	was	 body	mass	
loss	 and	 lower	 Ins,	 as	 compared	with	 the	 respective	
values	in	the	Dm	and	D	groups	(P <	0.05	or	P <	0.01).	
Meanwhile,	the	BG,	HbA1C,	and	Ins	in	the	Dm	group	
differed	from	the	corresponding	values	in	the	D	group;	
the	body	mass	was	an	exception	(Fig.	1).
The state of behavioral activity in experimental 
groups.	After	all	the	models	were	formed	successfully,	
the intensities of horizontal and vertical movements 
and the number of cleaning behavior episodes were 
F i g. 2. Mean values of the behavioral indices 
demonstrated	 in	 the	 open	 field	 test	 by	 animals	 of	
the	 examined	 groups.	 A)	 Horizontal	 movements;	
B)	 vertical	 movements;	 C)	 time	 spent	 in	 the	 central	
square;	D)	number	of	grooming	acts,	 and	E)	number	
of	 defecations	 within	 the	 observation	 period.	 Other	
designations	are	similar	to	those	in	Fig.	1.
Р и с. 2.	Середні	значення	поведінкових	показників,	
продемонстрованих	у	тесті	відкритого	поля	твари-
нами	досліджених	груп.	
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reduced	 compared	with	 the	N	group,	while	 the	 time	
spent	in	the	central	square	and	number	of	defecations	
increased (P <	 0.01).	Horizontal	 and	 vertical	motor	
activities and number of grooming episodes in the 
DmD1	 and	 DmD2	 subgroups	 were	 significantly	
smaller	than	those	in	the	Dm	and	D	groups	(P <	0.05	
or P <	0.01).	However,	 the	time	in	the	central	square	
and number of defecations were greater than those 
in	 the	 latter	 groups.	We	 also	 found	 that	 there	was	 a	
marked difference in these five parameters between 
the	Dm	and	D	groups.	Compared	with	the	Dm	group,	
the numbers of horizontal and vertical movements and 
cleaning	motions	were	smaller	(down-regulated)	in	the	
D	group,	but	 the	 time	 in	 the	central	grid	and	number	
of	defecations	increased	(up-regulated).	There	were	no	
statistically	significant	difference	between	the	DmD1	
and	DmD2	subgroups	(Fig.	2).
Contents of monoamine transmitters in the 
thalamus of rats of experimental groups. HPLC- 
measurements	of	 the	 contents	of	DA,	5-HT,	 and	NE	
using in the thalamus of animals of different groups 
showed that the contents of these transmitters in the 
model groups were reduced significantly compared 
with the indices in normal rats (P <	0.05	or	P <	0.01;).	
The	contents	of	NE,	DA	and	5-HT	 in	 the	DmD1	and	
DmD2	subgroups	were	lower	than	those	in	the	Dm	and	
D	groups.	There	was	no	significant	difference	between	
the	DmD1	and	DmD2	subgroups	(Fig	3).
State of the neuroendocrine axis in the 
experimental groups. We	 also	 tested	 the	 state	
of the hypothalamo-pituitary-adrenal axis in the 
model	groups.	Compared	with	 the	normal	group,	 the	
contents	of	ACTH	and	Cort	in	the	three	model	groups	
were higher (P <	 0.01);	 and	 the	 contents	 of	 these	
F i g. 3. Contents	of	monoamine	transmitters	in	the	thalamus	of	animals	of	the	studied	groups.	A-C)	Levels	of	norepinephrine	(A,	ng/g),	
dopamine	(B,	ng/g),	and	5-hydroxytryptamine	(C,	ng/g).	Other	designations	are	similar	to	those	in	Fig.	1.
Р и с. 3.	Вміст	трансмітерів-моноамінів	у	таламусі	тварин	досліджених	груп.	
F i g. 4.	Concentrations	of	ACTH	(A,	ng/
liter)	and	cortisol,	Cort	(B,	pg/ml)	in	the	
examined	groups.	Other	designations	are	
similar	to	those	in	Fig.	1.
Р и с. 4.	 Концентрації	 АКТГ	 (A)	 та	
кортизолу	 (B)	 у	 тварин	 досліджених	
груп.	
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F i g 5. Expression	of	NPY	protein	in	the	hypothalamus	of	rats	of	the	exthamined	groups.	A)	Results	of	Western	blotting;	B)	diagram	of	the	
relative	level	of	NPI	protein,	arbitrary	units.	Other	designations	are	similar	to	those	in	Fig.	1.
Р и с. 5.	Експресія	протеїну	NPY	в	гіпоталамусі	тварин	досліджених	груп.
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hormones	in	the	Dm	and	D	groups	were	different	from	
the respective values in the two diabetes-depression 
subgroups	(DmD1	and	DmD2).	The	contents	of	ACTH	
and Cort in both latter subgroups were considerably 
higher	 than	 those	 in	 the	 Dm	 and	 D	 groups.	 No	
statistical	 difference	was	 found	 between	 the	DmD1	
and	DmD2	subgroups	(Fig	4).
Reduction of the NPY mRNA and protein 
contents in the hypothalamus of the diabetes-
depression group. Using	real-time	PCR	and	Western	
blotting,	 we	 estimated	 the	 NPY	mRNA	 and	 protein	
levels	 in	 the	 diabetes-associated	 depression	 model.	
The	RT	PCR	 results	 showed	 that	 the	 levels	 of	NPY	
mRNA	in	the	D	group	and	DmD1	subgroup	were	lower	
than that in the normal group (P <	0.01;	Table	6).	The	
respective	level	in	the	DmD1	subgroup	was	lower	than	
those	in	the	Dm	and	D	groups	(P <	0.01).	Meanwhile,	
the	Western	blotting	 results	 indicated	 that	 the	 levels	
of	NPY	protein	in	the	Dm,	D,	and	DmD1	groups	were	
lower than the respective value in the normal group 
(P <	0.05;	Fig	5).
DISCUSSION
Diabetic	 patients	 manifest	 a	 number	 of	
pathopsychological	 shifts,	 such	 as	 an	 unhealthy	
general	 psychological	 state	 [4],	 character	 defection,	
and	 emotional	 disorders	 [1-3].	 Successful	 building	
of	 a	 sufficiently	 adequate	 animal	model	 of	 diabetes-
related depression is very important for the research 
of depression induced by diabetes mellitus	in	humans.	
We	 used	 two	 approaches	 to	 form	 the	 diabetic	
depression	 animal	 model.	 The	 first	 method	 was	
keeping	and	feeding	rats	alone	after	STZ	induction	of	
diabetes mellitus.	 In	 the	 second	mode,	 the	 rats	were	
exposed to chronic unpredictable mild stress induced 
by various everyday randomized stress-inducing 
sessions.	 Our	 results	 showed	 that	 both	 diabetes	
depression subgroups demonstrated clearly manifested 
unhealthy	behavior,	torpid	responses,	retarded	actions,	
and also reduction of furry glossiness and decrease in 
food	 and	 water	 consumption.	All	 these	 phenomena	
conform to the main symptoms of endogenous 
depression	and	 indicate	 that	our	diabetes+depression	
model	was	built	effectively.	
Lustman	 et 	 a l . 	 suggested	 that 	 depression	
additionally	 suppress	 secretion	of	 islet	 cell,	 reduces	
glycometabolism,	and	promotes	increase	in	the	blood	
glucose	level	[5,	6].	Our	results	also	indicated	that	the	
levels of glucose and glycosylated hemoglobin in the 
diabetes depression subgroups were higher than those 
in	 the	“pure”	diabetes	group,	and	 the	 Ins	 level	 in	 the	
above two subgroups was noticeably lower than that 
in	the	latter	group.	These	results	suggest	that	there	is	
a close relationship between generation of diabetes-
related	depression	and	elevated	blood	glucose	level.
Until	 now,	 it	 is	 acknowledged	 that	 a	 functional	
deficiency	 in	 5-HT	 is	 the	main	 biochemical	 change	
under	 conditions	 of	 depression	 [7,	 8].	 The	 diabetic	
animal	models	manifested	 a	 similar	 feature	 [9].	Our	
studies	 show	 that	 the	 levels	of	5-HT	 in	 the	 thalamus	
in	Dm,	D,	and	DmD	animals	were	significantly	lower	
than	 that	 in	 the	 normal	 group.	 In	 the	 two	 diabetic	
depression	 subgroups,	 the	 reduction	 of	 5-HT	 was	
most	considerable.	Our	 results	confirm	 that	diabetes 
mellitus and depression are correlated and potentiate 
the	dysfunction	 resulting	 in	suppression	of	 the	5-HT	
system.
In	 some	 studies,	 it 	 was	 found	 that	 the	 NE	
concentration is changed in both depression and 
diabetes	models	 [7,	 10,	 11].	 Paschos	 et	 al.	 reported	
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that derepression of NE is up-regulated in the 
peripheral	nervous	system,	and	 the	NE	concentration	
is	 reduced	 in	 the	 hippocampus	 [12].	 Ferraro	 et	 al.	
found that the concentration of NE increased in the 
blood plasma of patients with type I diabetes mellitus 
[13,	 14].	 Nonetheless,	 data	 on	 the	 concentration	 of	
NE	 in	 diabetes	 depression	 are	 limited.	 In	 our	 study,	
we revealed that the level of NE in the thalamus of 
animals of all three model groups was significantly 
lower	 compared	 with	 the	 normal	 group.	 In	 the	 two	
diabetes	depression	subgroups	(the	entire	DmD	group),	
the	shifts	were	the	greatest.
Many	studies	have	demonstrated	that	the	synthesis,	
delivery,	 re-uptake,	 and	 metabolism	 of	 DA	 are	
abnormal in diabetes mellitus and also in depression 
[15].	In	the	brain	of	depressive	rats,	the	content	of	DA	
was	found	to	be	remarkably	reduced	[10].	On	the	other	
hand,	it	was	reported	that	the	content	of	DA	in	the	rat	
brain	increased	significantly	on	the	8th	week	of	type	II	 
diabetes.	 In	 other	 works,	 it	 was	 suggested	 that	 the	
DA	content	did	not	 change	 in	 the	 cerebral	 cortex	of	
diabetic	 rats.	 In	our	study,	we	 found	 that	 the	content	
of	 DA	 in	 the	 thalamus	 of	 model	 groups	 was	 lower	
than	 that	 in	 the	 normal	 group.	These	 changes	 in	 the	
DmD	group	 (both	 subgroups)	were	most	 significant.	
Disagreements	 between	 the	 above	 data	may	 be	 due	
to differences between rat strains and to different 
formulations	of	the	long-term	experimental	cycle.	The	
absence of an effective treatment for diabetic rats in 
our experiments could intensify the reduction of the 
DA	level	in	the	brain	of	diabetic	depressive	rats.	
It is generally recognized that the hypothalamo-
pituitary-adrenal	 axis	 (HPAA)	 not	 only	 plays	 an	
important role in the development of depression 
and	diabetes	but	 is	also	closely	 related	 to	 stress	 [12,	
16].	 The	 levels	 of	ACTH	 and	 Cort,	 two	 important	
hormones	 in	 this	 axis,	 are	 up-regulated	 in	 chronic	
stress	[12,	17].	After	the	antidepressant	treatment,	the	
concentrations	of	these	hormones	are	down-regulated.	
A corresponding situation was also found in diabetic 
patients	without	depression.	However,	little	is	known	
on	the	concentration	of	ACTH	and	Cort	in	the	plasma	
of	 diabetics	 with	 depression.	 Our	 research	 showed	
that	 the	 up-regulated	 concentrations	 of	ACTH	 and	
Cort	in	both	subgroups	of	the	DmD	group	were	more	
significant	than	those	in	the	Dm	and	D	groups;	in	other	
words,	 a	 combination	 of	 diabetes	 with	 depression-
inducing influences promotes pathological shifts in 
the	HPA.	
It was reported that expression of NPY is down-
regulated in a gentle-depression model and in patients 
with	depression	[18].	As	was	also	mentioned,	the	level	
of NPY mRNA and the respective protein is higher 
in	 the	hypothalamus	of	diabetic	 rats	 [19].	Our	 study	
demonstrated that the level of NPY mRNA and protein 
is down-regulated in the hypothalamus of animals 
of the three model groups compared with that in the 
normal	 group,	 and	 shifts	 in	 the	 DmD	 group	 were	
most	significant.	Our	results	for	the	Dm	group	are	not	
consistent	 with	 the	 previous	 reports.	We	 think	 that	
such a discrepancy may be related to the fact that the 
diabetic rats did not obtain effective treatment and the 
higher blood glucose was not relieved in the long-term 
experiment.	All	these	factors	increased	the	intensity	of	
depression and led to the reduction of NPY mRNA and 
protein	in	the	hypothalamus	of	experimental	animals.	
In	 general, 	 our	 results	 demonstrated	 that	 a	
combination	 of	 STZ-induced	 diabetes	 and	 chronic	
moderate unpredictable repetitive stress stimulation 
or behavioral isolation of the rats can stably lead to 
the formation of an animal model diabetes-related 
depression.	The	depressed	state	 in	 this	model	can	be	
maintained	for	a	long	time.	Therefore,	both	the	above-
mentioned two modes of combined action have allowed 
us	 to	 build	 an	 adequate	 animal	 model	 of	 diabetes-
associated	 depression.	 The	 DmD2	 subgroup,	 where	
rats	were	kept	 in	 isolation,	appears	more	suitable	 for	
empirical studies because of the lower mortality of the 
animals.	
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Р	е	з	ю	м	е
Ефективність	досліджень	механізмів	депресії,	пов’язаної	з	
цукровим	діабетом,	обмежується	недостатністю	адекватних	
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експериментальних	моделей.	Із	80	щурів	ми	сформували	чо-
тири	групи:	нормальну	(N,	контроль),	групу	Dm	із	стрепто-
зотоциніндукованим	експериментальним	діабетом,	групу		D	
з	ознаками	депресії,	 індукованої	помірними	за	силою,	але	
тривалими	повторюваними	різноманітними	стресогенними	
стимуляціями,	що	реалізувалися	в	рандомізованому	поряд-
ку	щоденно	протягом	чотирьох	тижнів,	а	також	групу	DmD,	
котра	складалася	зі	щурів	 із	діабетом,	підданих	хронічним	
стресогенним	впливам.	Остання	група	(35	тварин)	була	роз-
ділена	на	дві	підгрупи:	DmD1,	піддану	вказаним	стресоген-
ним	стимуляціям,	 та	DmD2,	в	якій	щури	з	діабетом	утри-
мувалися	в	ізоляції	протягом	аналогічного	періоду	(чотири	
тижні).	У	щурів	груп	Dm,	D	 і	DmD	проявлялися	виражені	
поведінкові	симптоми	депресії.	Ці	симптоми	були	порівня-
но	слабкими	в	групі	Dm	 і	найбільш	 інтенсивними	в	групі	
DmD.	Маса	 тіла	 тварин	помітно	 зменшувалася	порівняно	
з	нормою	в	групах	Dm	і	D	та	різко	падала	в	групі	DmD.	У	
цій	групі	пов’язані	з	діабетом	зміни	рівнів	глюкози	в	крові,	
інсуліну	та	гемоглобіну	А1С	були	найбільшими.	Те	ж	саме	
стосувалося	поведінкових	індексів,	що	визначалися	в	щурів	
у	тесті	відкритого	поля.	Рівні	норадреналіну,	серотоніну	та	
дофаміну	в	таламусі	щурів	груп	Dm,	D	і	DmD	були	нижчими	
за	норму;	ці	 зрушення	виявилися	найбільш	драматичними	
в	групі	DmD.	Рівні	АКТГ	і	кортизола	в	експериментальних	
групах	зростали;	ці	зміни	також	були	найбільш	значними	в	
групі	DmD.	Виміри	з	використанням	полімеразної	ланцю-
гової	реакції	та	Вестерн	блоттингу	вказували	на	зниження	
рівня	протеїну	NPY	в	групах	Dm,	D	 і	DmD.	Таким	чином,	
помірна	 за	 силою	 хронічна	 непередбачувана	 стресогенна	
стимуляція	 або	поведінкова	 ізоляція	щурів	 із	діабетом	 іс-
тотно	збільшують	прояви	депресії	та	забезпечують	стабіль-
не	формування	адекватної	діабет-залежної		моделі	депресії	
в	експериментах	на	тваринах.	Утримання	щурів	у	 ізоляції	
(підгрупа	DmD2)	виглядає	більш	придатним	для	емпірич-
них	досліджень,	оскільки	смертність	тварин	у	даній	підгру-
пі	була	нижчою.
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